Pharma Journalist -

Longeveron LLC, a biopharmaceutical company that develops stem cell therapies for aging-related diseases, announced that the company has appointed Arin Maercks as chief commercial…
Read More...

Alnylam Pharmaceuticals announced that the European Commission (EC) has granted marketing authorization for ONPATTRO (patisiran) for the treatment of hereditary transthyretin-mediated…
Read More...

PolyActiva Pty Ltd, a clinical-stage Australian biotechnology company, has recently recruited first patients into its Phase I clinical study designed to show its glaucoma implant is…
Read More...

Pfizer Inc. announced that it is terminating two ongoing clinical studies evaluating domagrozumab (PF-06252616) for the treatment of Duchenne muscular dystrophy (DMD): a Phase 2 safety…
Read More...

Merck announced that the U.S. Food and Drug Administration (FDA) has approved two new HIV-1 medicines: DELSTRIGO, a once-daily fixed-dose combination tablet of doravirine (100 mg),…
Read More...

SunGen Pharma announced that it has entered into a Manufacturing Agreement with Grand River Aseptic Manufacturing to manufacture generic injectable pharmaceutical products. “We are…
Read More...

REGENXBIO Inc. announced that it is developing a new product candidate, RGX-181, for the treatment of late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease, one of the…
Read More...

UPM Pharmaceuticals, a Contract Development and Manufacturing Organization (CDMO) focused on oral solid and semi-solid drug dosage forms, has appointed Dr. Chi-Chang Wung to the…
Read More...

The Indian Pharma Expo 2018 was inaugurated on Tuesday 7th August at Pragati Maidan New Delhi by Shri. Sachin Kumar Singh CEO, Bureau of Pharma PSUs of India (BPPI), Dr. P. L. Sahu…
Read More...

Trovagene announced that the European Commission (EC) has endorsed the positive opinion of the Committee for Orphan Medicinal Products (COMP) and has granted Orphan Drug Designation…
Read More...